Teprotumumab has been game changer in management of thyroid eye disease

Click here to read the cover story, Neuro-ophthalmology enters new era of treatment
Thyroid eye disease is a debilitating, inflammatory autoimmune condition associated with Graves’ disease that is hard for patients, both physically and psychologically.
When you think about an acute disease such as bacterial pneumonia, patients have rapid onset of symptoms, are prescribed an antibiotic, and are usually on their way to being better after a 10-day course. Patients understand and tolerate these types of medical issues.
Thyroid eye disease, however, has its onset over the course of weeks and